Your Article Summary
See Latest ArticlesHigh-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases
Clinical Reviews in Allergy and Immunology, 06/30/09
Ishii N et al. - Randomized controlled trials are necessary to better determine the efficacy and adverse effects of IVIG in the treatment of autoimmune bullous skin diseases. In addition, insights into IVIG's mode of action might enable us to develop novel therapeutics to overcome the current shortage of IVIG.
Related Articles
Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09
Relevance Score: 66%
Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 64%
Prevalence and distribution of solitary oral pigmented lesions: a prospective study
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 63%
Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus
Clinical and Experimental Dermatology, 10/08/09
Relevance Score: 63%
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09
Relevance Score: 47%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam
Pharmacoepidemiology and Drug Safety, 12/09/09